Medicine and Dentistry
Aneuploidy
94%
Cell-Free DNA
88%
Neoplasm
55%
Circulating Tumor Cell
46%
Breast Cancer
45%
Lymph Node
40%
Prostate Cancer
40%
Screening Test
39%
Circulating Tumor DNA
35%
Liquid Biopsy
33%
Metastatic Carcinoma
28%
Primary Tumor
22%
Estrogen Receptor
22%
Castration Resistant Prostate Cancer
20%
Cerebrospinal Fluid
20%
Urothelial Cancer
20%
Liver Metastasis
20%
Metastatic Colorectal Cancer
20%
DNA Methylation
20%
Methylation
20%
DNA Sequence
20%
Pembrolizumab
20%
Metastatic Breast Cancer
20%
Colon Carcinoma
20%
Retrospective Study
20%
Proliferating Cell Nuclear Antigen
20%
Cell Count
18%
Hazard Ratio
16%
Next Generation Sequencing
13%
Disease Free Survival
13%
Microsatellite Instability
13%
Proportional Hazards Model
13%
Blood Donor
11%
Cytotechnology
10%
Exon
10%
Gene Frequency
9%
Biological Marker
8%
Colorectal Liver Metastasis
6%
Sanger Sequencing
6%
Cancer Staging
6%
Tumor Progression
6%
Tumor Localization
6%
Colon Tumor
6%
Diseases
6%
Overall Survival
6%
Aromatase Inhibitor
6%
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase
5%
Alpha Chain
5%
Cell Line
5%
Molecular Diagnostics
5%
Biochemistry, Genetics and Molecular Biology
Aneuploidy
100%
Screening Test
53%
Circulating Tumor DNA
47%
Methylation
40%
DNA Methylation
40%
Next Generation Sequencing
40%
Germline
20%
FABP1
20%
IGFBP3
20%
Cell Adhesion
20%
Quantitative Reverse Transcription Polymerase Chain Reaction
20%
Prospective Study
20%
DNA Sequence
20%
Germ Cell
20%
Mesenchymal-Epithelial Transition
20%
Pembrolizumab
20%
Primary Cell
20%
Estrogen Receptor
20%
Exon
20%
Blood Plasma
16%
Gene Frequency
14%
Cell Count
13%
Aromatase Inhibitor
10%
Phosphatidylinositol-4,5-bisphosphate 3-Kinase
10%
Alpha Chain
10%
Enzyme Active Site
10%
Wild Type
10%
Alpha 1-Antitrypsin
6%
CpG Island
6%
Tumor Suppressor Gene
5%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
88%
Aneuploidy
71%
Prostate Cancer
40%
Circulating Tumor DNA
32%
Primary Tumor
21%
Estrogen Receptor
21%
Breast Cancer
20%
Metastatic Breast Cancer
20%
Cyclin E
20%
Malignant Neoplasm
20%
Pembrolizumab
20%
Cycline
20%
Liver Metastasis
20%
Metastatic Colorectal Cancer
20%
Retrospective Study
20%
Castration Resistant Prostate Cancer
19%
Taxane
10%
Biological Marker
6%
Aromatase Inhibitor
6%
